Tuesday, January 16, 2024 3:42:48 PM
All posts are IMHO!
Recent ELAB News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:28:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 12:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 01:03:47 PM
- Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity • GlobeNewswire Inc. • 10/22/2024 01:54:26 PM
- Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity • GlobeNewswire Inc. • 10/21/2024 11:30:00 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/09/2024 10:02:17 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 10/04/2024 09:26:25 PM
- Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock • GlobeNewswire Inc. • 10/04/2024 09:08:26 PM
- Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations • GlobeNewswire Inc. • 10/03/2024 07:45:00 PM
- Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations • GlobeNewswire Inc. • 10/03/2024 11:30:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/02/2024 08:01:03 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/27/2024 09:11:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 10:27:49 AM
- Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB) • GlobeNewswire Inc. • 09/24/2024 09:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/24/2024 01:27:53 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/24/2024 01:26:44 PM
- Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering • GlobeNewswire Inc. • 09/23/2024 12:45:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/23/2024 04:15:14 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/19/2024 10:13:16 AM
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications • GlobeNewswire Inc. • 09/10/2024 11:30:24 AM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 09/06/2024 08:45:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:43:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 12:00:43 PM
- Micro Cap Stealing Premarket Show Before Tuesday's Opening Bell • AllPennyStocks.com • 09/03/2024 02:25:00 PM
- Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM